Top 10 Generic Drug Sustainability & Green Chemistry Initiatives in India

Robert Gultig

5 January 2026

Top 10 Generic Drug Sustainability & Green Chemistry Initiatives in India

User avatar placeholder
Written by Robert Gultig

5 January 2026

Introduction:

The pharmaceutical industry in India has been rapidly expanding in recent years, with a focus on sustainability and green chemistry initiatives. According to recent statistics, the generic drug market in India is expected to reach $33.18 billion by 2023, growing at a CAGR of 9.3%. This growth is driven by increasing demand for affordable healthcare solutions and a push towards environmentally-friendly practices.

Top 10 Generic Drug Sustainability & Green Chemistry Initiatives in India:

1. Cipla Limited
– Cipla Limited is a leading pharmaceutical company in India, known for its sustainable practices. It has reduced its carbon emissions by 30% over the past five years and has implemented green chemistry initiatives in its manufacturing processes.

2. Sun Pharmaceutical Industries Limited
– Sun Pharmaceutical Industries Limited has been actively involved in sustainability efforts, with a focus on reducing water consumption and waste generation. It has received recognition for its green chemistry initiatives in the industry.

3. Dr. Reddy’s Laboratories Ltd.
– Dr. Reddy’s Laboratories Ltd. has made significant strides in sustainable manufacturing practices, including the use of renewable energy sources and reducing its carbon footprint. It has been a pioneer in implementing green chemistry initiatives in its production processes.

4. Lupin Limited
– Lupin Limited has invested in environmentally-friendly technologies to reduce its impact on the environment. It has implemented green chemistry initiatives to minimize waste generation and promote sustainability in its operations.

5. Aurobindo Pharma Limited
– Aurobindo Pharma Limited has been recognized for its commitment to sustainability and green chemistry initiatives. It has implemented innovative solutions to reduce its environmental footprint and promote eco-friendly practices in the pharmaceutical industry.

6. Glenmark Pharmaceuticals
– Glenmark Pharmaceuticals has taken proactive steps towards sustainability, including the adoption of green chemistry principles in its manufacturing processes. It has received accolades for its efforts to reduce its carbon emissions and promote eco-friendly practices.

7. Torrent Pharmaceuticals
– Torrent Pharmaceuticals has prioritized sustainability in its operations, focusing on reducing energy consumption and waste generation. It has implemented green chemistry initiatives to minimize its environmental impact and promote sustainable practices in the pharmaceutical sector.

8. Cadila Healthcare
– Cadila Healthcare has made sustainability a key focus area, with initiatives to reduce water consumption and promote energy efficiency. It has implemented green chemistry practices to minimize its carbon footprint and contribute to a greener pharmaceutical industry.

9. Divi’s Laboratories
– Divi’s Laboratories has been at the forefront of green chemistry initiatives in India, with a commitment to sustainable manufacturing practices. It has invested in renewable energy sources and innovative technologies to reduce its environmental impact and promote eco-friendly operations.

10. Biocon Limited
– Biocon Limited has been a leader in sustainable practices in the pharmaceutical industry, with a focus on green chemistry initiatives. It has implemented strategies to reduce waste generation and promote sustainability in its manufacturing processes.

Insights:

The pharmaceutical industry in India is increasingly focusing on sustainability and green chemistry initiatives to reduce its environmental impact and promote eco-friendly practices. With the growing demand for generic drugs worldwide, companies are recognizing the importance of adopting sustainable manufacturing processes to stay competitive in the market. According to industry forecasts, the adoption of green chemistry initiatives is expected to continue to rise, with a projected growth of 12% in the next five years. This trend highlights the industry’s commitment to environmental sustainability and the shift towards a greener future for pharmaceutical manufacturing.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →